Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/1999
10/28/1999WO1999054306A1 Isoquinolinesulfonamide derivatives and drugs containing the same as the active ingredient
10/28/1999WO1999054301A1 Substituted 2-oxo-alkanoic acid-[2-(indol-3-yl)-ethyl] amides
10/28/1999WO1999054299A1 Pyrrolidines as inhibitors of neuraminidases
10/28/1999WO1999054290A1 Inhibitors of neuraminidases
10/28/1999WO1999053960A2 Enhancing immune responses to genetic immunization by using a chemokine
10/28/1999WO1999053950A2 Live vaccines and methods of treatment therewith
10/28/1999WO1999053948A1 Chlamydia proteins and their uses
10/28/1999WO1999053913A1 Topical formulations for the treatment of nail fungal diseases
10/28/1999WO1999053911A1 Antifungal agents
10/28/1999WO1999053897A2 Topical formulation comprising poloxamers and further microbicides, and an applicator
10/28/1999WO1999053762A1 A method for efficient and highly selective control of microorganisms
10/28/1999WO1999053754A1 Subversion of bacterial resistance by low solubility antibiotics
10/28/1999WO1999041404A3 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
10/28/1999WO1999040937A3 Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
10/28/1999WO1999040936A3 Pneumococcal and meningococcal vaccines formulated with interleukin-12
10/28/1999WO1999039691A3 Pharmaceutical compositions
10/28/1999WO1999036092A3 Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells
10/28/1999WO1999034832A8 Crystallographically stable amorphous cephalosporin compositions and process for producing the same
10/28/1999WO1999032516A3 Pharmaceutical compositions containing the long pentraxin ptx3
10/28/1999WO1998040099A9 Leptospira pathogens
10/28/1999DE19818802A1 Stable mitoxantron solutions useful for cancer therapy
10/28/1999CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999CA2329660A1 Inhibitors of neuraminidases
10/28/1999CA2329422A1 Pyrrolidines as inhibitors of neuraminidases
10/28/1999CA2328967A1 A method for efficient and highly selective control of microorganisms
10/28/1999CA2328875A1 Substituted 2-oxo-alkanoic acid-[2-(indol-3-yl)-ethyl] amides
10/28/1999CA2328364A1 Production of furanones
10/28/1999CA2326685A1 Enhancing immune responses to genetic immunization by using a chemokine
10/28/1999CA2326002A1 Chlamydia proteins and their uses
10/28/1999CA2325848A1 B-cell growth factor related protein
10/28/1999CA2325553A1 Topical formulations for the treatment of nail fungal diseases
10/27/1999EP0952220A2 Method to predict active growth of bacteria adhered to a surface
10/27/1999EP0952218A2 Single chain, multiple antigen-binding molecule, its preparation and use
10/27/1999EP0952213A2 Process for inducing an immune response mediated by NK-cells
10/27/1999EP0952157A1 9A, 11B-Dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin
10/27/1999EP0952151A2 Intermediates for use in preparing novel pyridonecarboxylic acid derivatives or their salts
10/27/1999EP0952149A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors
10/27/1999EP0951563A1 A new eia test using non-dentured hiv antigen for early detection of hiv infection
10/27/1999EP0951554A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
10/27/1999EP0951552A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications
10/27/1999EP0951480A1 Method and novel compounds for use therein
10/27/1999EP0951474A1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
10/27/1999EP0951473A1 Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
10/27/1999EP0951469A1 Novel compounds
10/27/1999EP0951467A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
10/27/1999EP0951299A1 Method of producing active immunity with vaccine conjugate
10/27/1999EP0951285A1 Inhibitors of farnesyl-protein transferase
10/27/1999EP0951281A2 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR
10/27/1999EP0544907B1 Antibacterial penem esters derivatives
10/27/1999CN1233285A Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria
10/27/1999CN1233258A Method for producing an IgM preparation for intravenous administration
10/27/1999CN1233257A Polypeptide transition metal salts and method of enhancing anti-HIV activity of polypeptide
10/27/1999CN1233254A Purine L-nucleosides, analogs and uses thereof
10/27/1999CN1233187A HIVp-17 peptide fragment, compositions containing and methods for producing and using same
10/27/1999CN1233186A A method for the treatment of streptococcus pneumoniae infection
10/27/1999CN1233184A Pharmaceutical and comestic formulations with antimicrobial activity
10/27/1999CN1233183A Pharmaceutical and cosmetic antiacne formulations containing plant extracts (Krameria triandra or mesua ferrea)
10/27/1999CN1233169A Process for the manufacture of a pulverous preparation
10/27/1999CN1232704A Culture process of high-yield weak-toxicity distemper cell strain
10/27/1999CN1232681A Hog cholera treating medicine
10/27/1999CN1232674A Chinese medicine preparation for curing radically chronic tonsilitis and intractable laryngopharyngitis and its preparation and usage
10/26/1999US5973224 Dietetical combination preparations
10/26/1999US5973128 Glycolipid mimics and methods of use thereof
10/26/1999US5973009 Antioxidant and cytoprotecting activity
10/26/1999US5972989 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/26/1999US5972969 Methods of combatting infectious disease using dicationic bis-benzimidazoles
10/26/1999US5972955 Water soluble C-ring analogues of 20(S)-camptothecin
10/26/1999US5972940 Arginine analogues having nitric oxide synthase inhibitor activity
10/26/1999US5972933 Method of treating microbial infections
10/26/1999US5972928 Administering an antigrowth agent
10/26/1999US5972899 Apoptosis induced by Shigella IpaB
10/26/1999US5972701 Nucleotide sequence of ribo- or deoxyribonucleotides which may have modified sugars, bases, or phosphates; for hybridization and cleavage of rna targets; treatment of disease
10/26/1999US5972688 HTm4 methods of treatment and assays, agonists and antagonists
10/26/1999US5972666 Assembly-deficient herpesvirus vaccine
10/26/1999US5972652 Polynucleotides encoding secreted proteins
10/26/1999US5972651 Polynucleotides and polypeptides of the fifty-four homologue family, (ffh); vectors and transformed host cells; ffh are components of protein secretory apparatus and their inhibition of function is deleterious to bacteria cells
10/26/1999US5972650 Can be used as vehicles for the delivery of nucleic acids that can serve as therapeutic agents and as part of vaccines designed to immunize people or animals against viral diseases.
10/26/1999US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/26/1999US5972596 Nucleic acid constructs containing HIV genes with mutated inhibitory/instability regions and methods of using same
10/26/1999US5972379 Liposomes having a surface coating of hydrophilic polymer chains and an entrapped ciprofloxacin-amino acid conjugate, useful for treating the bacterial infections
10/26/1999US5972369 Includes reservoir comprising beneficial agent and capillary channel in communication with reservoir and exterior of system for delivering beneficial agent from system
10/26/1999US5972350 Prevention and treatment of chlamydia diseases in cats
10/26/1999US5972349 Synthesis of polyribosylribitol phosphate oligosaccharides
10/26/1999US5972348 Nickel binding protein and its encoding dna isolated from helicobacter pylori; useful as vaccine, diagnostic, drug target, and therapy in itself
10/26/1999US5972347 Pharmaceutical composition containing a neutralized virus and use thereof
10/26/1999US5972346 Hepatitis b surface antigen, in combination with aluminum phosphate and 3-o-acylated monophosphoryl lipid a.
10/26/1999US5972339 Method of eliciting anti-HIV-1 helper T cell responses
10/26/1999US5972337 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein
10/26/1999US5972336 Urease-based vaccine against helicobacter infection
10/26/1999CA1340801C Optically active pyridonecarboxylic acid derivatives
10/21/1999WO1999053053A1 Gene coding for heliomicine and use thereof
10/21/1999WO1999053047A2 Porcine adenovirus type 3 genome
10/21/1999WO1999053043A2 Herpes simplex virus latency associated transcript polypeptides
10/21/1999WO1999053026A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
10/21/1999WO1999053020A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae
10/21/1999WO1999052939A1 Peptides
10/21/1999WO1999052910A1 Bicyclic hydroxamic acid derivatives
10/21/1999WO1999052889A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
10/21/1999WO1999052862A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors
10/21/1999WO1999052562A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
1 ... 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 ... 1798